Clinical trials have consistently demonstrated the efficacy of Duratia in treating premature ejaculation and improving quality of life for affected individuals. These studies have shown that Duratia significantly increases intravaginal ejaculatory latency time (IELT) and improves various measures of sexual satisfaction and relationship quality. However, further research is needed to explore long-term effects, optimal dosing strategies, and potential interactions with other medications. While clinical studies provide valuable insights into Duratia's efficacy, patient experiences offer a more nuanced understanding of its impact on quality of life. Many men who have used Duratia report significant improvements in ejaculatory control, sexual satisfaction, and overall well-being. However, individual responses vary, and some may experience side effects or find the medication ineffective. Therefore, it's essential for individuals considering Duratia to discuss their options with a healthcare professional and weigh the potential benefits and risks.